ULTRA-condensed knowledge
Opportunity, MIT SMR + BCG
EXCEPTIONAL “Full Pack Golden Knowledge Container”
This transportation and logistics company relies on AI to deliver COVID-19 vaccines safely and efficiently.
- When Ranjeet Banerjee talks about the work his organization, Cold Chain Technologies (CCT), does to transport vaccines and other biologics that must be temperature controlled, he stresses that the company doesn’t solely rely on technology. CCT approaches its work by first considering what problems it’s trying to solve, developing use cases, and then considering whether a technology solution might be the best way forward.
- In this episode of the Me, Myself, and AI podcast, we learn how a combination of Ranjeet’s background in chemical engineering, his experience working in the health care space, and a holistic approach to leadership and problem-solving enable him to lead CCT to constantly innovate in the supply chain space. Ranjeet also discusses the benefits of a customer-first mindset and shares insights applicable to leaders in industries beyond health care.

Genioux knowledge fact condensed as an image
References
ME, MYSELF, AND AI, EPISODE 305, AI in the Supply Chain: Cold Chain Technologies’ Ranjeet Banerjee, Sam Ransbotham and Shervin Khodabandeh, January 11, 2022, MIT Sloan Management Review, MIT SMR, Boston Consulting Group,
BCG.
ABOUT THE HOSTS
Sam Ransbotham (@ransbotham) is a professor in the information systems department at the Carroll School of Management at Boston College, as well as guest editor for MIT Sloan Management Review’s Artificial Intelligence and Business Strategy Big Ideas initiative. Shervin Khodabandeh is a senior partner and managing director at BCG and the coleader of BCG GAMMA (BCG’s AI practice) in North America. He can be contacted at shervin@bcg.com.
Me, Myself, and AI is a collaborative podcast from MIT Sloan Management Review and Boston Consulting Group and is hosted by Sam Ransbotham and Shervin Khodabandeh. Our engineer is David Lishansky, and the coordinating producers are Allison Ryder and Sophie Rüdinger.
Ranjeet Banerjee, Cold Chain Technologies
Ranjeet Banerjee is the CEO of Cold Chain Technologies (CCT), a leading global provider of comprehensive thermal assurance solutions for temperature-sensitive drugs, vaccines, and biologics. Under his leadership, CCT is playing a key role in the COVID-19 pandemic response, with both the Moderna and Johnson & Johnson vaccines exclusively using CCT’s thermal assurance packaging solutions across the U.S. CCT is also supporting the in-transit cold chain needs for vaccine distribution across the globe. Previously, Banerjee spent 25 years at global medical technology company Becton Dickinson, most recently serving as corporate executive vice president as well as president of the U.S. and Canada regions, with responsibility for more than $6 billion in revenue. Banerjee is a member of the Advisory Board for the CEO Leadership Alliance of Orange County. He earned a bachelor’s degree in chemical engineering from the Indian Institute of Technology.
Extra-condensed knowledge
Lessons learned, MIT SMR + BCG
Golden Knowledge (GK) Juice
- Ranjeet Banerjee: I joined Cold Chain Technologies in August of 2020, and it’s been a very exciting journey. What excited me about the company and what it does and the entire industry space it’s in is the potential to really transform and address a key need [when] it comes to the life sciences industry, and that is the need for … really, the simplest way I can say this is, how do you provide assurance when you are transporting drugs, biologics, [and] vaccines over long distances, over complicated routes? How are you providing assurance that the product that is getting transported is meeting all the right conditions and ensuring safety and efficacy? That’s the challenge statement that got me excited about Cold Chain Technologies, which is what this company does. So CCT, or Cold Chain Technologies, is the leader in thermal assurance packaging for life sciences. At the time when I was taking on the role, COVID was starting to become an important topic — a pandemic — and since then, we’ve also played a huge role in supporting the distribution of COVID vaccines.
Condensed knowledge
- CONTEXT: The Golden Knowledge Path ("GKPath") digital highway
Opportunity, Discovering and exploiting the treasure of the digital age
- "genioux facts", the online programme on MASTERING “THE BIG PICTURE OF THE DIGITAL AGE”, builds The Golden Knowledge Path (GKPath) digital highway to discovering and exploiting the treasure of the digital age, accelerating everyone's success in the digital age. g-f(2)254, g-f(2)260, g-f(2)261, g-f(2)251, g-f(2)312, g-f(2)256, g-f(2)257, g-f(2)272, g-f(2)271, g-f(2)270, g-f(2)268, g-f(2)269, g-f(2)289, g-f(2)283, g-f(2)287, g-f(2)313, g-f(2)293, g-f(2)294, g-f(2)296, g-f(2)298
- The inverted mini pyramid of knowledge, g-f(256), is essential to travel on the "GKPath" highway.
- g-f(2)256 The Big Picture of the Digital Age (5/2/2021), geniouxfacts, The fundamental knowledge mini-pyramid for traveling on the "GKPath" highway.
- Key "genioux facts" to travel on the "GKPath" highway.
Lessons learned, MIT SMR + BCG
Golden Knowledge (GK) Juice
- Ranjeet Banerjee: Imagine now there is a drug being transported. It’s stuck at an airport. A lot of drugs are air-freighted, so they’re stuck at the airport. Now you want to know: OK, there’s a delay; is that a meaningful delay? And if so, what actions do we need to take? So when you start translating this from simple visibility to providing assurance, that’s where AI comes in.
- Shervin Khodabandeh: This probability is an interesting take on packaging and logistics. So if I understand correctly, one of the applications of how you’re using AI is to figure out the likelihood that that item that’s being transported is going to get to the recipient not just in time and in place, but also intact or in usable form. Is that right?
- Ranjeet Banerjee: Correct.
- Shervin Khodabandeh: This is quite fascinating because I have to imagine a lot of our audience is familiar with the inherent complexities of just the typical logistics problem, which is something has to go from point A to point B and go through a global supply chain with lots of disruptions, and that’s a multimillion-parameter problem, which is a typical logistics problem. Now, Ranjeet, you’re talking about overlaying a whole bunch of other conditions — about temperature and delays and packaging integrity and a lot of other things — that make this one or two or three orders of magnitude even more complex. I could imagine that’s going to be a daunting problem for any human to solve, which is where AI comes in, I would assume.
- Ranjeet Banerjee: Exactly. And we are also realistic that this is going to be a multigenerational approach, and you’ve got to kind of crawl, walk, and run. But if you step back … technology always is an enabler to solve problems, right? It’s not an end in itself. But the goal here is what I like calling, “How do you deliver assurance when you are transporting drugs and pharmaceuticals?” How do you deliver assurance — assurance as defined by, “Will the drug be effective when it reaches its intended point of use, or not? And will it be on time, and will it be effective?” And it’s really a whole new value chain creation.
- Ranjeet Banerjee: I personally am a big believer — and our team believes this too — [that] you don’t lead with technology; you lead with what are the challenges that are out there and then come back and say, “What technologies can be used to address those challenges?” So we started — and we did this over the last year or so — we spent a lot of time talking to the stakeholders, understanding. We also had internal experts. So we started with our own kind of view on what the industry issues are. We went to talk to customers. And we started creating these use cases. Each use case is a real-life problem that technology can potentially solve. We didn’t even ask what kind of technology yet. It’s just like, “OK, what’s the problem first?”
- Sam Ransbotham: Well, take us from chemical engineering, then. How did you get interested in artificial intelligence and machine learning as technologies?
- Ranjeet Banerjee: Personally, different people have different points of view, but my point of view is this is a whole new revolution that is happening, where, using technologies that we did not have before, we can solve so many challenges that we could not before. And these challenges are … it’s in health care, it’s in financial, in fintech. It’s in so many areas. It’s in what we just discussed. In every part of the world, in every business, and in every organization, it’s almost like you have to step back and say, “Look, let’s make a list of these big, hairy problems we have never been able to tackle for the last 20 years and kind of step back and say, ‘What can we do? How can we tackle these now through the use of technology?’”
Some relevant characteristics of this "genioux fact"
- Category 2: The Big Picture of the Digital Age
- [genioux fact deduced or extracted from MIT SMR + BCG]
- This is a “genioux fact fast solution.”
- Tag Opportunities those travelling at high speed on GKPath
- Type of essential knowledge of this “genioux fact”: Essential Analyzed Knowledge (EAK).
- Type of validity of the "genioux fact".
- Inherited from sources + Supported by the knowledge of one or more experts.
- Authors of the genioux fact
References
ABOUT THE AUTHORS
PhD with awarded honors in computer science in France
Fernando is the director of "genioux facts". He is the entrepreneur, researcher and professor who has a disruptive proposal in The Digital Age to improve the world and reduce poverty + ignorance + violence. A critical piece of the solution puzzle is "genioux facts". The Innovation Value of "genioux facts" is exceptional for individuals, companies and any kind of organization.
- A list of relevant "genioux facts" that describe a "Classical CONTEXT" of the Digital Age
- g-f(2)45 "The Big Picture of the Digital Age": Knowledge opens the way to staggering opportunities, risks and challenges
- g-f(2)50 The Big Picture of the Digital Age: Mines of Golden Knowledge Growing Every Day
- g-f(2)74 THE BIG PICTURE OF THE DIGITAL AGE: Rapid change, incertitude and disruption, in a hypercompetitive environment
- g-f(1)28 The pyramid of knowledge of a “genioux fact”: From GOLD FRUITS to GOLD JUICES
- g-f(2)51 The Big Picture of the Digital Age: The Value of Golden Knowledge is Relative
- g-f(2)99 THE BIG PICTURE OF THE DIGITAL AGE, The “genioux facts”: Essential knowledge to unleash your limitless growth.
- g-f(2)75 THE BIG PICTURE OF THE DIGITAL AGE: “Infinite Learners” to keep pace with change, incertitude and disruption, in a hypercompetitive environment
- g-f(2)151 The Big Picture of the Digital Transformation, 3/1/2021, geniouxfacts, How To Succeed At Business Digital Transformation.
- g-f(2)153 The Big Picture of Business Artificial Intelligence (3/3/2021) in a Single “g-f KBP” Chart
- g-f(2)174 THE BIG PICTURE OF THE DIGITAL AGE (3/20/2021), geniouxfacts, Executive guide of golden knowledge to fire up your unlimited growth.
- Some key searches on the blog